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ABSTRACT To study the molecular mechanisms of local anesthesia, locations of local anesthetic dibucaine in model
membranes and the interactions of dibucaine with a Na+ channel inactivation gate peptide have been studied by 2H- and
1H-NMR spectroscopies. The 2H-NMR spectra of dibucaine-d. and dibucaine-d1, which are deuterated at the butoxy group
and at the 3 position in its quinoline ring, respectively, have been observed in multilamellar dispersions of the lipid mixture
composed of phosphatidylcholine, phosphatidylserine, and phosphatidylethanolamine. 2H-NMR spectra of deuterated
palmitic acids incorporated, as a probe, into the lipid mixture containing cholesterol have also been observed. An order
parameter, SCD, for each carbon segment was calculated from the observed quadrupole splittings. Combining these results,
we concluded that first, the butoxy group of dibucaine is penetrating between the acyl chains of lipids in the model
membranes, and second, the quinoline ring of dibucaine is located at the polar region of lipids but not at the hydrophobic acyl
chain moiety. These results mean that dibucaine is situated in a favorable position that permits it to interact with a cluster of
hydrophobic amino acids (lle-Phe-Met) within the intracellular linker between domains Ill and IV of Na+ channel protein, which
functions as an inactivation gate. To confirm whether the dibucaine molecule at the surface region of lipids can really interact
with the hydrophobic amino acids, we synthesized a model peptide that includes the hydrophobic amino acids (Ac-
GGQDIFMTEEQK-OH, MP-1), the amino acid sequence of which corresponds to the linker part of rat brain type IIA Na+
channel, and the one in which Phe has been substituted by Gin (MP-2), and measured 1H-NMR spectra in both phosphate
buffer and phosphatidylserine liposomes. It was found that the quinoline ring of dibucaine can interact with the aromatic ring
of Phe by stacking of the rings; moreover, the interaction can be reinforced by the presence of lipids. In conclusion, we wish
to propose that local anesthesia originates from the ir-stacking interaction between aromatic rings of an anesthetic molecule
located at the polar headgroup region of the so-called boundary lipids and of the Phe in the intracellular linker between
domains IlI and IV of the Na+ channel protein, prolonging the
proceed to the resting state.
inactivated state and consequently making it impossible to
INTRODUCTION
Since the discovery by Sigmund Freud in Heidelberg of
local anesthesia by cocaine, many chemicals have been
proposed as local anesthetics (Ritchie and Greene, 1985;
Covino, 1987). Their molecular structures have a similarity
in that they have the following chemical arrangement: an
aromatic ring, an intermediate chain including an amide or
an ester linkage, and a tertiary amine nitrogen. Thus these
chemicals are amphiphilic in nature, and owing to the pres-
ence of the tertiary amine nitrogen, they can exist as both
cationic and uncharged molecular forms, depending on their
PKa and the pH of the fluid surrounding nerve membranes.
The mechanism of action of the local anesthetics upon
excitable membranes, which appears to be well established
so far, is 1) diffusion of the uncharged form of the local
anesthetic across the nerve sheath and nerve membrane; 2)
reequilibration between the uncharged and cationic forms
on the axoplasmic surface of the nerve membrane; and 3)
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penetration into and attachment to a receptor at a site within
the sodium channel (Covino, 1987; Strichartz and Ritchie,
1987). However, the molecular nature of the local anesthetic
site(s) of action remains unclear. Debate has focused on
whether such sites are purely lipid in nature or whether
protein targets may be involved. A good correlation be-
tween the potency of local anesthetics and their ability to
penetrate artificial lipid membranes gives support for the
former view (Trudell, 1977, 1980), whereas the use-depen-
dent anesthetic block, the stereospecific effects of local
anesthetics, and the higher affinity binding of anesthetic for
the inactivated channels than for the activated ones support
the latter (Strichartz and Ritchie, 1987; Courtney and Stri-
chartz, 1987).
Recently two notable papers that urge us to study the
molecular mechanisms of local anesthesia have been pub-
lished. One is related to the Na+ channel inactivation gate in
rat brain type IIA Na+ channel by Catterall et al. (Patton et
al., 1992; West et al., 1992), and the other is related to the
amine blockers of the cytoplasmic mouth of Na+ channels
by Zamponi and French (1994). Catterall et al. have re-
ported that they successfully specified the amino acid resi-
dues required for fast Na+ channel inactivation and have
proposed a "hinged-lid" model of the Na+ channel inacti-
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vation gate (Patton et al., 1992; West et al., 1992). In this
model, a cluster of hydrophobic amino acids, Ile-1488,
Phe-1489, and Met-1490 within the intracellular linker be-
tween domains III and IV of the channel protein (Fig. 1),
occludes the intracelluar mouth of the activated Na+ chan-
nel (Fig. 2) and stabilizes the inactivated state, making use
of Gly-1484 (or Gly-1485, or both) and Pro-1509 residues
on either side of the IFM domain as hinge points. On the
other hand, Zamponi and French have reported that for a
drug to function as an inactivation enhancer, it is necessary
that the aromatic ring of the drug bind to a hydrophobic
domain (Fig. 2) within the internal mouth of the channel
(Zamponi and French, 1994).
By taking these two reports into consideration and by
noting that there are negatively charged amino acids only on
both sides of the IFM amino acid residues (Asp-1487,
Glu-1492, and Glu-1493; see Figs. 1 and 2) in the linker, we
hypothesized as follows: 1) local anesthetics locate within
lipid membranes surrounding domains III and IV, allowing
their hydrophobic moieties to interact simultaneously with
both lipids and one or two of the three hydrophobic amino
acids of Ile-1488, Phe-1489, or Met-1490; 2) the tertiary
amine nitrogen, especially in its protonated quaternary am-
monium form, interacts electrostatically with one of the
three negatively charged amino acids that occur on both
sides of the three hydrophobic amino acids. These assump-
tions can explain all of the reasoning involved in the two
conflicting models of molecular mechanisms of local anes-
thesia. However, for these assumptions to be proved correct,
as a first step we should confirm whether all local anesthetic
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FIGURE 2 A hinged-lid model for Na+ channel inactivation (Patton et
al., 1992; West et al., 1992) and schematic representation of the interaction
between a local anesthetic drug and the amino acid residues in the inacti-
vation gate peptide.
molecules reside at the polar headgroup region of the mem-
branes, rather than at the hydrophobic acyl chain region.
This is because the "hinged lid" occupies a position within
the aqueous channel pore (Fig. 2), and thus local anesthetics
should also locate at a site within the hydrophilic regions of
the channel. We assumed that such an interfacial site be-
tween the hydrophobic site suggested by Zamponi and
Ill IV
.N.. .....GGQDIFMTEEQKK ........... F
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FIGURE 1 Schematic representation for the Na+-channel a subunit. It is considered to be composed of four homologous domains (I-IV). Each domain
has six a-helices (1-6). A space that is surrounded by the 24 a-helices is thought to be a pore through which the Na+ ion passes (Noda et al., 1986). The
numbering and the amino acid sequence at the intracelluar linker between domains III and IV is in the rat brain IIA Na+ channel (Noda et al., 1986).
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French and the hydrophilic region in which the hinged-lid
exists is provided by the polar headgroup region of the
so-called boundary lipids, and not by the channel protein.
The local anesthetic dibucaine (Fig. 3) was selected for
use in the present experiments. The molecule consists of a
big quinoline ring, which seems to be the most hydrophobic
aromatic ring among the clinically used local anesthetics.
Therefore, elucidating its location in lipid membranes can
be a promising means of testing the above assumptions.
2H-NMR spectroscopy has been employed to investigate
the location of the dibucaine molecule (Seelig, 1977).
The 2H-NMR spectra of the deuterated dibucaine at the 3
position in its quinoline ring and at the butoxy group in
multilamellar dispersions of phospholipids, composed of
phosphatidylcholine (PC), phosphatidylserine (PS), and
phosphatidylethanolamine (PE, PC:PS:PE = 1:1:2.5 mo-
lar ratio), which contain or do not contain cholesterol
(phospholipids:cholesterol = 7:3 molar ratio), have been
observed. The ratio of the amount of each lipid (PC:PS:
PE = 1:1:2.5 molar ratio) is that reported for the phos-
pholipids at the inside of human erythrocyte ghost (Op
den Kamp, 1979), whereas the ratio of the amount of the
total phospholipids to cholesterol (7:3 molar ratio) is
approximately one-half that reported for the total phos-
pholipids and cholesterol of the whole human ghost (Ma-
raviglia et al., 1982), but approximately equal to that
reported for the excitable membranes of the garfish ol-
factory nerve (Chacko et al., 1976). Moment analyses
(Bloom et al., 1978; Davis et al., 1979; Nichol et al.,
1980) have been applied to the observed 2H-NMR spec-
tra, because the observed spectra are made up by the
superposition of spectra due to variously oriented dibu-
caine molecules.
Effects of dibucaine on the orientational order of meth-
ylene groups of the multilamellar dispersions of phospho-
lipids have been studied by 2H-NMR spectroscopy. Deuter-
ated palmitic acid was incorporated into the lipid mixture as
a probe of the lipid structure. An order parameter SCD for
each carbon segment was calculated from the quadrupole
splitting in the 2H-NMR spectra. By taking all of these
2H-NMR spectroscopic data into account, we deduced the
location of dibucaine in membranes and concluded that the
quinoline ring of dibucaine is located at the polar headgroup
region of lipids.
To ascertain whether the dibucaine molecule located at
the polar headgroup region of lipids can actually interact
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with the hydrophobic amino acids, especially with Phe, we
synthesized a model peptide that includes the IFM domain
in the linker (Ac-GGQDIFMTEEQK-OH) named MP- 1 and
another in which Phe has been substituted by Gln (MP-2).
'H-NMR spectra of dibucaine in the presence of MP-1 or
MP-2 in both phosphate buffer and phosphatidylserine li-
posomes have been observed to obtain information on the
interactions. Finally, we discuss all of the results in relation
to the interaction between local anesthetics and the Na+
channel inactivation gate to elucidate the molecular mech-
anisms of local anesthesia.
MATERIALS AND METHODS
Materials
Dibucaine hydrochloride deuterated at the 3 position in the quinoline ring
(dibucaine-d,) was synthesized from isatin according to the scheme shown
in Fig. 4 (Miescher, 1932) (m.p. 91-96°C). The percentage of deuteration
was checked by 'H-NMR spectroscopy and was found to be 83%; this
rather low percentage of deuteration was later found to be due to the use of
C4H9OH instead of C4H9OD at the final stage of the reaction. The dibu-
caine hydrochloride deuterated at the butoxy group was synthesized by
using C4D9OH instead of C4H9OH (Fig. 4). The percentage deuteration
was greater than 99% (m.p. 91-96°C). Palmitic-d2 acids deuterated at
various positions (C4, C6, C9, or C10) were synthesized starting from
relevant a-deuterated fatty acids and dicarboxylic acid monomethyl esters
by the method of Kolbe electrolysis (Greaves et al., 1950); we followed the
method described by Oldfield et al. (1978). The percentages of deuteration
were checked by 'H-NMR spectra and found to be greater than 85% for
each palmitic-d2 acid. Palmitic-d3, acid was obtained from MSD Iso-
topes (Montreal, Quebec, Canada). Palmitic-2,2-d2 acid and palmitic-
3,3-d2 acid were obtained from C/D/N Isotope Inc. (Vaudreuil, Quebec,
Canada). Peptides MP-1 (Ac-GGQDIFMTEEQK-OH) and MP-2 (Ac-
GGQDIQMTEEQK-OH) were synthesized by the solid phase method
using Fmoc chemistry; their N-termini were acetylated (denoted by Ac-),
and their C-termini were free carboxylic acids (denoted by -OH). They
were purified on a reverse-phase C18 high-performance liquid chromatog-
raphy column using a gradient of 85% A, 15% B to 60% A, 40% B, where
A is 0.1% trifluoroacetic acid (TFA) in water and B is 0.1% TFA in
acetonitrile; the rate of decrease in A was 25%/50 min. They were char-
acterized by determination of amino acid composition by ion spray mass
spectrometry.
Egg yolk L-a-phosphatidylcholine (egg PC), bovine brain L-a-phospha-
tidylserine (PS), egg yolk L-a-phosphatidylethanolamine (PE), and choles-
terol were obtained from Sigma and used without further purification.
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FIGURE 3 Chemical structure of dibucaine hydrochloride and the num-
bering scheme.
FIGURE 4 Reaction scheme to synthesize the dibucaine deuterated at
the 3 position in the quinoline ring.
1193Kuroda et al.
Volume 71 September 1996
Deuterium-depleted water (<5 X 10-5 atom %D) was obtained from
ISOTEC (Miamisburg, OH).
Determination of the gel-to-liquid crystalline phase transition tempera-
ture of multilamellar dispersions of the lipid mixture composed of PC, PS,
and PE (PC:PS:PE = 1:1:2.5 molar ratio) was made by monitoring the lock
signal provided from an isotonic (310 mOsm, 150 mM) phosphate buffer
in 2H20 and was found to be 274 K.
The partition coefficients of dibucaine for the lipid mixture that contains
cholesterol and palmitic acid and dispersed in the phosphate buffer (pH 7.2
and pH 5.2) were obtained by fluorometrically determining the concentra-
tions of dibucaine not binding with the membranes. The measured solu-
tions were obtained by ultrafiltration of the lipid mixture suspended in the
phosphate buffer.
Preparation of sample solutions for
2H-NMR measurements
Lipid mixture solutions
The thin films of the mixtures of PC, PS, and PE (PC:PS:PE = 1:1:2.5
molar ratio, 60-70 mM) that contain or do not contain cholesterol (phos-
pholipids:cholesterol = 7:3 molar ratio) were prepared by concentrating
their chloroform/methanol solution with a rotary evaporator and then
pumping on a vacuum line overnight. Their multilamellar dispersions were
prepared by vortexing vigorously the round-bottomed flask containing the
thin films and an isotonic (310 mOsm, 150 mM, pH 7.4 or 5.6) phosphate
buffer in deuterium-depleted water for 5 min. A weighed amount of
dibucaine-d, (12 mM) or dibucaine-dg (3 mM) dissolved in the phosphate
buffer was added before the vortexing. To equilibrate the state of anes-
thetics interacting with lipids completely, the multilamellar dispersions of
model membranes were subjected to five freeze-thaw-vortex cycles (West-
man et al., 1982). Finally, the pH of the sample solution was checked and
adjusted to a desired value by adding a trace amount of Na2HPO4 or
NaH2PO4.
Lipid mixture solutions with cholesterol and deuterated
palmitic acid
The PC, PS, and PE in a chloroform/methanol solution (60 mM) were
mixed with cholesterol (25 mM) and deuterated palmitic acid (20 mM), and
then the solvent was evaporated by pumping with a vacuum line overnight.
Thus obtained thin films were dispersed into the deuterium-depleted water
(310 mOsm, pH 7.4 or 5.8) by vortexing. A weighed amount of dibucaine
(3 mM) was dissolved in the suspension and then subjected to five
freeze-thaw-vortex cycles.
Preparation of sample solutions for
H-NMR measurements
A weighed amount of dibucaine hydrochloride (3 mM) with or without
peptide (3 mM) was dissolved in the phosphate buffer (10% 2H20-90%
H20, 310 mOsm, 150 mM), and the pH of the sample solution was adjusted
to 7.4 by adding a trace amount of Na2HPO4 or NaH2PO4. Single bilayer
vesicles (liposomes) of PS were prepared by ultrasonic irradiation of the
phosphate buffer suspension (in 2H20) of dried PS (15 mM) for 20 min,
cooling in an ice/water bath, and bubbling with nitrogen gas. A weighed
amount of dibucaine (3 mM) with or without peptide (3 mM) was added to
the solution of preformed vesicles; the pH was adjusted to 7.4 by adding a
trace amount of Na2HPO4 or NaH2PO4.
Measurements
2H-NMR spectra were observed at 92 MHz on a Bruker AM-600 spec-
trometer equipped with a usual broadband probe for high-resolution NMR
spectroscopy. The quadrupolar echo sequence was employed (Davis et al.,
1976); r/2 = 10 ,us, and its pulse spacing was 50 ,us. A typical observing
spectral width was 50,000 Hz for 16 K data points, and the recycle time
was 0.26 s. The acquired number of transients was typically 300,000 (-22
h) for a sample solution containing dibucaine-dl, 200,000 (-15 h) for a
sample solution containing dibucaine-dg, and 250,000 (-20 h) for a sample
solution containing 20 mM deuterated palmitic acid. No symmetrization
procedure was performed. An exponential weighting function with a line
broadening factor of 50-100 Hz was applied to the free induction decay
acquired with 16 K data points and zero-filled to 64 K. The quadrupole
splittings reported in the following were read directly from the CRT
display of an AM-600 spectrometer. 'H-NMR spectra were observed on a
Bruker AM-600 (600 MHz) spectrometer with a digital resolution of 0.18
Hz/point; the ambient probe temperature was 27°C. The chemical shifts
were referenced to TSP (3-trimethylsilyl-propionic acid-d4 sodium salt).
Moment analyses for 2H-NMR spectra and
calculations of order parameters, SCD, for the
segments of a flexible hydrocarbon chain
Moments of the 2H-NMR spectra (Bloom et al., 1978; Davis et al., 1979;
Nichol et al., 1980) were calculated according to
Mn= Wfnf(CO)do/f f(c)dw (1)
and by using IRIS Indigo for half the Fourier-transformed spectral data
points (- 16,000) written in the ASCII format according to the JCAMP-DX
norm (McDonald and Wilks, 1988) in a Bruker X-32 computer. The
half-spectra selected for calculations were from either the high- or the
low-frequency sides, which do not include the resonance due to the solvent.
Estimated errors in calculating the first (M1) and the second (M2) moments
and the resulting mean order parameter (SCD), which is defined by
(2)SCD = 2 aMl/(e2qQ/h)
and its dispersion (A2), defined by
A2 = M2/1.35M2- 1,
where e2qQ/h is the static quadrupole coupling constant, were within a few
percent. The order parameter SCD for each acyl chain carbon position
(Stockton et al., 1976) was calculated by correlating the corresponding
observed quadrupole splitting, Avq (in units of kilohertz), of specifically
deuterated palmitic acids to the order parameter in the following way:
Avq = 3/4(e2qQlh)ScD. (4)
RESULTS
2H-NMR spectra of dibucaine-d1 in lipid mixtures
Fig. 5, a and b, shows 2H-NMR spectra of dibucaine-dl (12
mM)-lipid mixture (70 mM) solutions at pH 7.4 and at 300 K
in the absence and in the presence of cholesterol (phospholip-
ids:cholesterol = 7:3 molar ratio), respectively. The dibucaine
in the lipid mixture without cholesterol gave a trapezoid line-
shape with an approximate maxium quadrupole splitting of 6.7
kHz. In contrast, this spectral feature drastically changed when
the lipid mixture included cholesterol (spectrum b) and re-
sulted in a narrow resonance with a half-height width of 0.6
kHz. The differences in these spectral features essentially dis-
appeared, however, when the temperature was lowered to 279
K and resulted in closely similar spectra (spectra c and d); the
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FIGURE 5 (a) 2H-NMR spectrum
of dibucaine-d, (12 mM) mixed lipid
(PC:PS:PE = 1:1:2.5 molar ratio, 70
mM) solution at pH 7.4 and at 300 K.
(b) As in a, but contains cholesterol
(phospholipids:cholesterol = 7:3 mo-
lar ratio). (c) As in a, but at 279 K. (d)
As in b, but at 279 K.
(d)
(a)
10 5 0 -5 -10 kHz 10 5 0 -5 -10 kHz
quadrupole splitting decreased in spectrum c, and the linewidth
at half-height increased in spectrum d. Because the gel-to-
liquid crystalline phase transition temperature of the lipid mix-
ture with no cholesterol was 274 K, there is no doubt that the
lipid mixture is in a liquid crystalline state. It is known that
cholesterol increases the order of the acyl chains of lipid
bilayers at temperatures above that of the gel-to-liquid crystal-
line phase transition (Stockton and Smith, 1976; Bloom and
Mouritsen, 1988). Thus the spectral change from spectrum a to
spectrum b can be considered to be due to changes in the
location of dibucaine toward the polar region, which may
result in decreased order of the quinoline rings of dibucaine
molecules. On the other hand, the close resemblance between
spectra c and d suggests that at a low temperature dibucaine
molecules locate at a similar environment with a similar man-
ner, irrespective of the presence or absence of cholesterol. The
change in the lineshape from spectrum a to spectrum c implies
that the quinoline ring of dibucaine was squeezed out of the
original binding site to the more unordered binding site as a
consequence of increased degree of order of the lipids owing to
decreased temperature.
A similar observation was also noted at pH 5.8. The
observed maximum quadrupole splitting was 4.6 kHz; this
value was somewhat smaller than that of the neutral solution
(6.7 kHz).
2H-NMR spectra of dibucaine-dg in lipid mixtures
Fig. 6 shows 2H-NMR spectra of dibucaine-dg (3 mM) in
multilamellar dispersions of the lipid mixture in the absence
(Fig. 6, a and c) and presence (Fig. 6, b and d) of cholesterol
at pH 7.4; spectra a and b were observed at 300 K and
spectra c and d at 279 K. As shown in spectrum a, each
methylene group of dibucaine-4 showed clearly resolved
quadrupolar splittings ranging from 12 to 4.5 kHz; however,
the methyl group showed no resolved splitting. In contrast
to the spectra for dibucaine-dl, all of these splittings in-
creased when the membrane contained cholesterol, and
even the terminal methyl group showed a clear quadrupolar
splitting of 1.8 kHz (spectrum b). When the temperature
was lowered to 279 K, the quadrupolar splittings due to the
methylene groups increased, ranging from 14.5 to 6.2 kHz
(spectrum c); however, those lineshapes became rather fea-
tureless in appearance. This tendency became more promi-
nent when the lipid mixture contained cholesterol (spectrum
d). The quadrupolar splittings due to the three methylene
groups coalesced to give a broad trapezoid lineshape with a
width of about 14 kHz, and that due to the methyl group
increased (3.0 kHz). These observations indicate that dibu-
caine molecules are binding with the lipid membrane in
such a manner that its butoxy group is between the acyl
chains of lipids.
Fig. 7 shows 2H-NMR spectra observed at acidic condi-
tions. The quadrupole splittings in spectrum a decreased by
about 0.4 kHz in each methylene group as compared to the
corresponding one in the neutral pH solution (Fig. 6 a).
However, no appreciable difference was noted when the
lipid mixture contained cholesterol (compare spectrum b
with Fig. 6 b). The tendencies for the spectral changes with
added cholesterol or a temperature lowered to 279 K were
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FIGURE 6 (a) 2H-NMR spectrum of dibu-
caine-dg (3 mM) mixed lipid (PC:PS:PE =
1:1:2.5 molar ratio, 70 mM) solution at pH 7.4
and at 300 K. (b) As in a, but contains choles-
terol (total lipids:cholesterol = 7:3 molar ra-
tio). (c) As in a, but at 279 K. (d) As in b, but
at 279 K.
(a)
10 5 0 -5 -10 (kHz)
10 5 0 -5
-100d¢
10 5 0 -5
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the same as those noted for neutral pH solutions, except that
spectrum c showed a more clear-cut quadrupole splitting for
each methylene group; in fact, even the methyl group showd
a small well-resolved quadrupole splitting (spectrum c).
Moment analyses for 2H-NMR spectra of
dibucaine-d, and dibucaine-d9
Moment analyses (Bloom et al., 1978) have been applied to
these 2H-NMR spectra because the observed spectra are
made up of a superposition of the spectra arising from
variously oriented dibucaine molecules. Tables 1 and 2
show the first (M1) and the second (M2) moments, mean
order parameter derived from the first moment (SCD), and
the mean square deviation of the order parameter (A2) of
dibucaine-dl and dibucaine-dg, respectively. The static
e2qQlh values assumed were 180 kHz (Burnett and Muller,
1971) in Table 1 and 167 kHz (Davis and Jeffrey, 1977) in
Table 2; the former is a typical value for the C-2H bond in
an aromatic ring, and the latter is for the C-2H bond in an
aliphatic chain. All of the changes in spectral features de-
scribed above were clearly reflected in these M1, M2, and
SCD values. Furthermore, we noticed that in dibucaine-d1
the distribution of order parameters that is represented by
the A2 value increased when the lipid mixture contained
cholesterol (from 0.379 to 0.887) or when the temperature
was lowered (from 0.379 to 1.02); under acidic conditions
the entirely same trend was noted. These findings mean that
the order of dibucaine binding with lipid membranes was
lowered by cholesterol and by lowering the temperature. On
the other hand, in dibucaine-dg, under both neutral and
acidic conditions, the A2 value decreased when the lipid
mixture contained cholesterol, but again increased when the
temperature was lowered. This former result means that in
contrast to the case in dibucaine-d,, the cholesterol in-
creases the order of the butoxy group of dibucaine in the
lipid bilayer. Because the butoxy group is attached to the
carbon adjacent to the 3 position in the quinoline ring, this
finding can be a good clue to the location of dibucaine.
2H-NMR spectra of palmitic acid probes in the
lipid mixture with cholesterol
To investigate the effects of dibucaine on the orientational
order of methylene groups of multilamellar dispersions of
phospholipids, we have observed 2H-NMR spectra for deu-
terated palmitic acids incorporated into the lipid mixture
with cholesterol. The usefulness of deuterated fatty acid
probes for determining the order of phospholipid mem-
branes is well demonstrated (Stockton et al., 1974, 1976;
Pauls et al., 1983; Vogt et al., 1994). Fig. 8 shows 2H-NMR
spectra observed for palmitic-d3l acid (25 mol%), which is
intercalated into multilamellar dispersions of the lipid mix-
ture with cholesterol at pH 7.2; spectrum a was obtained in
the presence of no dibucaine, whereas spectra b and c were
obtained in the presence of 1 mM and 3 mM dibucaine,
respectively. Each of these spectra had only six peaks,
because the 2H-NMR spectrum of palmitic-d3, acid is com-
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FIGURE 7 (a) 2H-NMR spectrum of dibu-
caine-dg (3 mM) mixed lipid (PC:PS:PE = 1:1:
2.5 molar ratio, 70 mM) solution at pH 4.8 and
at 300 K. (b) As in a, but contains cholesterol at
pH 4.6. (c) As in a, but at 279 K. (d) As in b, but
at 279 K.
10 5 0 -5 -10
(c)(a)
posed of many overlapping resonances; in an acidic condi-
tion (pH 5.2) the situation was the same as in the neutral
condition. The sharp peak at around 0 kHz should be
attributed to the residual HO2H resonance of the solvent.
The quadrupole splittings (Avq) in spectrum a were de-
creased by adding dibucaine to the multilamellar disper-
sions. However, we found that the peaks showing the qua-
drupole splitting of 32.1 kHz (labeled by an asterisk in
spectrum c) did not change on the addition of dibucaine; the
peaks were later found to be assignable to the C2 methylene
deuterons by comparison with the 2H-NMR spectrum for
palmitic 2,2-d2 acid. For all methylene and methyl group
deuterons, the spectrum observed at pH 7.2 was broader
than that at pH 5.2. Thus it is conceivable that the order of
the acyl chains of lipids under the acidic condition is lower
than that under the neutral condition. The quadrupole split-
tings of 5.91, 20.5, and 26.6 kHz can be assigned to the
10 5 0 -5 -10 (kHz)
terminal methyl (C16), methylene groups at 15- (C15), and
14- (C14) positions, respectively; the corresponding split-
tings under the acidic condition were 4.95, 17.9, and 23.8
kHz, respectively.
To obtain an order parameter for a specific carbon seg-
ment in the acyl chain, some palmitic acids that were
deuterated at the specific methylene groups were incorpo-
rated into the lipid mixture. Fig. 9, a and b, shows 2H-NMR
spectra of palmitic-2,2-d2 acid in the lipid mixture with and
without dibucaine, respectively. A quadrupole splitting of
32.1 kHz was observed when the lipid mixture contained no
dibucaine. However, notably, this quadrupole splitting
scarcely changed, even when the lipid mixture contained
dibucaine. A similar observation was noted for the probe
under acidic conditions; a quadrupole splitting of 31.0 kHz
was decreased very slightly (30.6 kHz) by the addition of
dibucaine. In contrast, for example, as shown in Fig. 10, a
TABLE I Moment data for the dibucaine-d,-mixed lipids (PC:PS:PE = 1:1:2.5 molar ratio) and dibucaine-dl-mixed lipids-
cholesterol (total lipids:cholesterol = 7:3 molar ratio) systems
Membrane pH Temperature M Ix 10-4(rad/s) M2 x 10 8(rad2/s2) SCD X 102 A2
Mixed lipids 7.4 300 1.16 2.51 3.56 0.379
279 0.715 1.40 2.19 1.02
5.8 300 1.03 1.64 3.16 0.141
279 0.904 1.51 2.77 0.364
Mixed lipids + cholesterol 7.4 300 0.333 0.282 1.02 0.887
279 0.707 1.14 2.17 0.689
5.8 300 0.366 0.542 1.12 2.00
279 0.955 1.69 2.93 0.375
(kHz)
10 5 0 -5 10(kHz)
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TABLE 2 Moment data for the dibucaine-d9-mixed lipids (PC:PS:PE = 1:1:2.5 molar ratio) and dibucaine-d9-mixed lipids-
cholesterol (total lipids:cholesterol = 7:3 molar ratio) systems
Membrane pH Temperature MI X 10-4(rad/S) M2 X 10-8(rad2/S2) SCD X 102 A2
Mixed lipids 7.4 300 1.02 2.08 3.37 0.477
279 1.20 3.02 3.96 0.558
4.8 300 1.13 2.73 3.74 0.579
279 1.22 2.71 4.02 0.360
Mixed lipids + cholesterol 7.4 300 1.55 4.18 5.11 0.293
279 1.98 6.57 6.53 0.242
4.6 300 1.44 3.70 4.76 0.322
279 1.96 6.55 6.47 0.264
and b, dibucaine decreased the quadrupole splitting (39.2
kHz) in the palmitic-9,9-d2 acid probe appreciably (37.1
kHz). Thus it seems that under both neutral and acidic
conditions, dibucaine is situated in a position that does not
so much affect the order parameter of the methylene groups
near the polar region, but affects appreciably that of the
methylene groups at an intermediate region of the acyl
chain. Interestingly, Boulanger et al. (1981) have reported
the same sort of finding in a tetracaine-deuterated PC dis-
persions system; they found that tetracaine affects only
slightly the quarupole splittings of the deuterons at position
2 in the deuterated PC dispersions. They ascribed this find-
ing to the location of the benzenoid group around the acyl
chain position 2. To further understand the effect of dibu-
caine on the quadrupole splittings throughout the acyl chain
methylene groups, we have observed 2H-NMR spectra for
the probes deuterated at C3, C4, C6, and CIO. All of the
observed quadrupole splittings at pH 7.2 and pH 5.2, with
and without dibucaine, are summarized in Table 3.
Order parameter profiles for palmitic
acids intercalated into the lipid mixture
containing cholesterol
To discuss differences in the order among chain segments,
we have calculated an order parameter (SCD) for each car-
bon number of the palmitic acid probe, according to Eq. 4
(Stockton et al., 1976). The SCD values for the neutral and
acidic solutions, calculated by assuming the static e2qQ/h
value of 170 kHz (Stockton et al., 1976), are summarized in
Table 3. To focus our attention on the changes in SCD
caused by 3 mM dibucaine (ASCD) (Fig. 1 1), we plotted the
ratios ASCD/SCD against carbon numbers. ASCD represents
the amount of decrease in the SCD value caused by dibu-
caine. It appears that under both neutral and acidic condi-
(b)
(a)
3
-.1.-. r.
30 20 10 0 -10 -20 -30 (kHz) 30 20 10
0 30
O -10 -20 -30 (kHz)
FIGURE 8 2H-NMR spectra of palmitic-d3i acid (20 mM) in mixed lipid
(PC:PS:PE = 1:1:2.5 molar ratio, 60 mM) solution with cholesterol (total
lipids:cholesterol = 7:3 molar ratio) at pH 7.2 and at 300 K. (a) Without
dibucaine. (b) With dibucaine (1 mM). (c) With dibucaine (3 mM).
FIGURE 9 2H-NMR spectra of palmitic-2,2-d2 acid (20 mM) in mixed
lipid (PC:PS:PE = 1:1:2.5 molar ratio, 60 mM) solution with cholesterol
(total lipids:cholesterol = 7:3 molar ratio) at pH 7.2 and at 300 K. (a)
Without dibucaine. (b) With dibucaine (3 mM).
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headgroups may be reasons for the finding in Fig. 11; in the
Discussion, however, we favor only the latter view.
30 20 10 ° -10 -20 -30 (kHz)
FIGURE 10 2H-NMR spectra of palmitic-9,9-d2 acid (20 mM) in mixed
lipids (PC:PS:PE = 1:1:2.5 molar ratio, 60 mM) with cholesterol (total
lipids:cholesterol = 7:3 molar ratio) at pH 7.2 and at 300 K. (a) Without
dibucaine. (b) With dibucaine (3 mM).
tions, the ratios monotonously increase from C2 to ClO, and
then gradually increase or remain approximately constant
from C10 to the terminal methyl group, C16. Moreover, we
notice that the ratio for the acidic solution is larger than that
at the corresponding carbon number for the neutral solution.
To confirm whether this finding is due to a larger amount of
dibucaine partitioning into the lipid mixture under acidic
than under neutral conditions, we have measured the parti-
tion coefficient Kp of dibucaine for the lipid mixture, which
involves cholesterol and palmitic acid. The results are sum-
marized in Table 4; the Kp value of 1108 at pH 7.2 compares
favorably with that reported by Papahadjopoulos et al.
(1975) for the lipid composition of PS/cholesterol (Kp =
1150). Evidently, the partition coefficient at pH 7.2 was
greater than that at pH 5.2. Thus we should invoke another
reason for the differences in the ratio. Interestingly, Bou-
langer et al. (1981) have reported a similar finding for
tetracaine interacting with multilamellar dispersions of spe-
cifically deuterated phosphatidylcholine, namely that the
charged tetracaine has a greater disordering effect on the
phospholipid chain region and perturbs to a greater extent
the dimensions of this region than does the uncharged one.
The pKa value of dibucaine reported is 8.0 (Kuroda et al.,
1994) or 8.5 (Ritchie and Greengard, 1961). Furthermore, it
is considered that the pKa value of the tertiary amino group
of the membrane bound drug would decrease by approxi-
mately I pKa unit from the corresponding value in the
aqueous phase (Lee, 1978). Accordingly, at pH 7.2, about
half of the dibucaine molecules can be considered to be in
an uncharged molecular form, whereas at pH 5.2 all of the
dibucaine molecules are expected to exist as a cationic form.
Consequently, the differences in the ratio ASC/SCD be-
tween pH 7.2 and pH 5.2 should also be ascribed to the
changes in the relative amount of uncharged versus charged
species. Changes in the location due to protonation and/or
electrostatic interactions between cationic drugs and lipid
'H-NMR spectra of dibucaine and Na+
channel inactivation gate peptide (MP-1) in a
phosphate buffer
To investigate a plausible interaction between dibucaine
and MP-1, especially the expected -n-stacking interaction
(Hunter, 1993; Hunter and Sanders, 1990; Jorgensen and
Severance, 1990) between the quinoline ring of dibucaine
and the phenyl group of Phe, we have measured 1H-NMR
spectra of dibucaine in the absence and in the presence of
MP- 1. As a control experiment, we also measured 1H-NMR
spectra of dibucaine in the presence of MP-2, in which the
Phe has been substituted by Gln. Fig. 12, a, b, and c, shows,
respectively, 1H-NMR spectra of MP-1 (3 mM), dibucaine
(3 mM), and dibucaine (3 mM)-MP-1 (3 mM) solutions in
a phosphate buffer at pH 7.4. In spectrum a the peaks in a
range of 7.2-7.4 ppm are due to aromatic ring protons of
Phe, and the other peaks are due to amide protons of the
peptide. In spectrum b the quinoline ring proton resonances
are assignable from high to low frequency, respectively, to
the 5, 8, 7, 6, and 3 positions. As can be seen in spectrum
c, it is evident that the quinoline ring protons at the 3 and 8
positions shifted appreciably to a lower frequency. Fig. 13,
a and b, shows 1H-NMR spectra of dibucaine (3 mM) and
dibucaine (3 mM)-MP-2 (3 mM) solutions in a phosphate
buffer at pH 7.4. Interestingly, in contrast to the observa-
tions in Fig. 12, no appreciable chemical shift changes were
noted for the proton resonances at the 3 and 8 positions. In
Fig. 14, we have schematically summarized observed
changes in chemical shifts (in units of hertz at 600 MHz) of
dibucaine protons as a result of interaction with MP-1 and
MP-2. As can be seen in Fig. 14, both MP-1 and MP-2
shifted the resonances due to polar side-chain moiety (pro-
tons a-d) of dibucaine to a higher frequency. These high-
frequency shifts can be ascribed to the electrostatic interac-
tion between the positively charged quaternary ammonium
group of dibucaine and the negatively charged carboxyl
group of Asp, Glu, or the C-terminus. On the other hand,
MP-1 shifted the resonances due to the butoxy group (pro-
tons f, g, and h) and all of the quinoline ring protons
(protons 3, 5, 6, 7, and 8) to a lower frequency. These
low-frequency shifts can be considered to be due to the
ring-current effect (Pople et al., 1959) originating from the
ir-stacking interactions between the quinoline ring of dibu-
caine and the phenyl group of Phe in MP- 1, because no such
chemical shift changes were caused by the presence of
MP-2 in the solution.
1H-NMR spectra of dibucaine and a Na+
channel inactivation gate peptide in
phosphatidylserine liposomes
To determine whether the dibucaine molecules that are
binding with lipids can interact with the Na+ channel inac-
(b)
(a)
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TABLE 3 Observed quadrupole splittings (Avq) and order parameters (ScD)* for deuterated palmitic acid probes intercalated in
mixed lipids with cholesterol at pH 7.2 and 5.2
pH 7.2 pH 5.2
Dibucaine 0 mM Dibucaine 3 mM Dibucaine 0 mM Dibucaine 3 mM
Chain segment Avq(kHz) SCD AVq(kHz) SCD Avq(kHz) SCD Avq(kHz) SCD
2 32.1 0.252 32.0 0.251 31.0 0.243 30.6 0.240
3 32.5 0.255 31.9 0.250 33.6 0.264 33.3 0.261
4 36.3 0.285 35.5 0.278 36.3 0.285 35.3 0.277
6 39.2 0.307 37.5 0.294 39.4 0.309 37.0 0.290
9 39.2 0.307 37.1 0.291 38.6 0.303 35.8 0.281
10 37.6 0.295 35.4 0.278 36.1 0.283 31.8 0.249
14# 26.6 0.209 24.9 0.195 23.8 0.187 20.9 0.164
15* 20.5 0.161 18.9 0.148 17.9 0.140 15.8 0.124
16# 5.91 0.046 5.49 0.043 4.95 0.039 4.38 0.034
*Calculated from the observed quadrupole splittings by using Eq. 4.
#Taken from the palmitic-d3, acid probe.
tivation gate peptide, we have observed 1H-NMR spectra of
dibucaine and the peptide in sonicated PS liposomes pre-
pared in deuterated phosphate buffer at pH 7.4. Fig. 15, a,
b, and c, shows, respectively, 'H-NMR spectra of dibucaine
(3 mM), dibucaine (3 mM)-MP-2 (3 mM), and dibucaine (3
mM)-MP-1 (3 mM) in the PS liposomes. As expected, the
quinoline ring proton resonances of dibucaine appeared as
broad resonances, reflecting interactions with the PS lipo-
somes; the resonance at the 5 position shifted to a higher
frequency, whereas all of the remaining resonances shifted
to a lower frequency as compared to the corresponding
chemical shift positions in the phosphate buffer solution. It
(%/o)
a
C.)
C,)
a
C.)
n1
14
12'
10'
2 4 6 8 10 12 14 16
Carbon Number
FIGURE 11 Plot of ASCD/SCD against positions of deuteration for spe-
cifically deuterated palmitic acid probes intercalated in mixed lipids with
cholesterol at pH 7.2 (a) and pH 5.2 (C]). ASCD represents the amount of
decrease in the SCD value caused by 3 mM dibucaine.
is worth noting that all of the quinoline proton resonances
shifted to a lower frequency, even on the addition of MP-2
(spectrum b). However, more remarkable is the fact that
MP-1 caused a larger low-frequency shift to those reso-
nances than did MP-2 (spectrum c). In Fig. 16 we show the
changes in chemical shifts of quinoline ring proton reso-
nances schematically. The reason for the changes in chem-
ical shift on the addition of MP-2 is not clear at present; this
should be explained together with the changes in chemical
shift of those resonances as a result of interaction with PS
liposomes. However, undoubtedly the larger low-frequency
shift caused by MP-1 compared to that caused by MP-2
should be ascribed to the rr-stacking interaction with the
phenyl group of Phe. Moreover, we notice that the chemical
shift differences between resonances in spectrum c and
spectrum b are two to six times larger than observed
changes in chemical shifts on the addition of MP- 1 in the
phosphate buffer (Fig. 14). This finding indicates that
-n-stacking interaction is enhanced when dibucaine mole-
cules simultaneously interact with both lipids and MP-1.
1H-NMR spectra of the phenyl group protons of
phenylalanine in MP-1
Fig. 17, a and b, shows 'H-NMR spectra of the phenyl
group protons of Phe, in the absence and in the presence of
dibucaine in the phosphate buffer, respectively. The spin-
coupled peaks at around 7.36, 7.32, and 7.27 ppm are due to
TABLE 4 Partition coefficients of dibucaine in the bilayer of
lipid mixture* with cholesterol* and palmitic acid§ at pH 7.2
and 5.2
Kp
Lipid pH 7.2 pH 5.2
PC:PS:PE 1108 557.1
*PC:PS:PE = 1: 1:2.5 molar ratio.
'Total lipids:cholesterol = 7:3 molar ratio.
§Total lipids:palmitic acid = 3:1 molar ratio.
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FIGURE 12 (a) 'H-NMR spectrum of MP-1 (3 mM) in a phosphate buffer at pH 7.4. (b) 'H-NMR spectrum of dibucaine (3 m) in a phosphate buffer
at pH 7.4. (c) 'H-NMR spectrum of dibucaine (3 mM)-MP-1 (3 mM) solution in a phosphate bufffer at pH 7.4. Assignments for the quinoline ring proton
resonances are given on top of the spectrum (c).
meta, para, and ortho protons, respectively. It was found
that dibucane shifted the phenyl group resonances very
slightly to a lower frequency (0.4 Hz in meta, 0.0 Hz in
para, and 1.3 Hz in ortho protons). Fig. 17, c and d, shows
1H-NMR spectra of the phenyl group protons of Phe of
MP-1 in PS liposomes. In Fig. 17 c, the chemical shifts of
the phenyl group protons were nearly identical to those of
the corresponding resonances in the phosphate buffer (Fig.
17 a), suggesting that the phenyl group of Phe locates at a
region that does not receive any shielding or deshielding
effect from the PS liposomes. However, in the presence of
dibucaine, we noticed that in contrast to the large low-
frequency shift of the quinoline ring proton resonances of
5
8
dibucaine, the phenyl group resonances of MP-1 shifted
slightly to a higher frequency (4.6 Hz in meta and para
protons, and 5.0 Hz in ortho protons). This result indicates
that the phenyl group protons are situated in positions with
respect to the quinoline ring that receive deshielding field
due to the ring current effect from the quinoline ring.
According to the theory for the aromatic ring-current effect
(Pople, 1959), this relative arrangement of the two aromatic
rings can be considered to be such that the ring protons of
Phe locate at the side of the quinoline ring of dibucaine and
that the quinoline ring protons locate on the plane of the
phenyl group of Phe. Although we cannot imagine the
interaction model that satisfies these situations for all of the
6
7
(a)
:;- 04
FIGURE 13 (a) 'H-NMR spectrum of dibucaine (3 mM) in a phosphate buffer at pH 7.4. (b) 'H-NMR spectrum of dibucaine (3 mM)-MP-2 (3 mM)
solution in a phosphate buffer at pH 7.4. Assignments for the quinoline ring proton resonances are given on top of the spectrum (b).
8.4 8.2 8.0 7.8 7.6 7.4 7.2 7.0 6.8 (ppm)
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FIGURE 14 Changes in chemical shifts (in units of hertz at 600 MHz) of
dibucaine as a result of interaction with MP- 1 and MP-2 in a phosphate
buffer at pH 7.4.
ring protons within one relative arrangement of the two
aromatic rings, an edge-on or T-shaped geometry for the
two ir-stacking aromatic rings seems to be a reasonable one
(Hunter and Sanders, 1990; Jorgensen and Severance,
1990). Taking rule 6 of Hunter et al. into account (Hunter
and Sanders, 1990), the quinoline ring can be considered to
be a ",T-deficient atom" and the phenyl group to be a
"ir-rich atom"; this finding agrees well with the a priori
expected result when we consider the differences in the
substituents on the aromatic rings.
DISCUSSION
Locations of dibucaine in model membranes
In the present study the location of dibucaine in model
membranes can be deduced by noting the following points:
1) changes in the quadrupole splittings of dibucaine-dl and
dibucaine-dg by cholesterol, by temperature, and by pH; 2)
changes in the quadrupole splittings of deuterated palmitic
acids by dibucaine. In conclusion, the quinoline ring of
dibucaine locates at a polar headgroup region, penetrating
the butoxy group between the acyl chains of the lipids. In
Fig. 18 we show this situation with computer graphics. The
lipid demonstrated here is dipalmitoylphosphatidylserine,
and its molecular structure is drawn tentatively, fully ex-
tending the acyl chains. The structure of cholesterol in egg
phosphatidylcholine bilayers is well investigated by x-ray
(Franks, 1976) and neutron diffraction (Worcester and
Franks, 1976) studies. Thus, in Fig. 18, the cholesterol was
so positioned as to locate its 3f3-hydroxyl group in the
vicinity of the acyl ester linkage or glycerol backbone,
spanning the polycyclic ring up to the first 8 to 10 methyl-
ene segments of the acyl chains, and extending the side
chain up to about the same depth in the bilayer (Stockton
and Smith, 1976). The dibucaine is presented as taking a
face-to-face ir-stacked dimer, because it has been shown
that dibucaine can exist as an aggregate in the lipid bilayer
(Wakita et al., 1992; Kuroda et al., 1994). One of the most
important results for deducing the location of dibucaine is
that the quadrupole splitting of dibucaine-dl dramatically
decreased when the multilamellar dispersions included cho-
lesterol, whereas those of dibucaine-dg increased by includ-
ing cholesterol. At first sight, the former observation ap-
pears to be explicable by changes in the membrane-aqueous
partitioning of the anesthetic by cholesterol. In fact, it is
reported that the partition coefficient of tetracaine between
dimyristoylphosphatidylcholine and a buffer at pH 9.5 de-
creases from 200 to 110 by including a 7:3 molar ratio of
cholesterol; at pH 5.5 it decreases from 21 to 8 (Auger et al.,
1988). However, the same reasoning cannot be applied to
the finding for the latter dibucaine-dg data, because the
quadrupole splittings of methylene and methyl groups were
increased by cholesterol. Because it is known that choles-
terol induces a high degree of order for the acyl chains of
phospholipids, it might be expected that if both the deuteron
at the 3 position of the quinoline ring and the deuterons of
the butoxy group that is attached to the 2 position locate
inside the glycerol backbone, the magnitude of their qua-
drupole splittings in both dibucaine-dl and dibucaine-dg
spectra would increase, reflecting the increased degree of
order caused by cholesterol molecules. However, this was
not the case; only the butoxy group deuterons showed
increased quadrupole splittings by cholesterol. To settle this
problem, it is inevitable that the carbon atom of the 3
position of the quinoline ring will be located near the acyl
ester linkage or glycerol backbone, causing the butoxy chain
to be approximately parallel to the acyl chains, as shown in
Fig. 18. For this binding situation, we can ascribe the
observed dramatic reduction in the quadrupole splitting of
dibucaine-dl caused by cholesterol to the decreased order of
the C-D vector at the 3 position; in fact, this was clearly
reflected in the increased A2 value shown in Table 1. The
decrease in order of the C-D vector at the 3 position seems
to arise from variations in the orientation of the quinoline
ring plane relative to the bilayer normal. Order parameter
profiles for palmitic acid probes shown in Fig. 11 give
support to the deduced location of dibucaine. We might
expect that if such a bulky group as a quinoline ring were
located in the middle of the acyl chain, the relevant part
would become rigid and result in an increased degree of
order. However, this was not the case, because the SCD
values of all of the monitored chain segments were de-
creased by the addition of dibucaine. This implies that the
bulky quinoline ring is located at the polar headgroup region
and not between the hydrophobic acyl chains. This applies
to both neutral and acidic conditions employed in this study.
Under neutral conditions, about half of the dibucaine mol-
ecules can be considered to exist in an uncharged molecular
form, whereas in the acidic condition, all of the dibucaine
molecules exist in a cationic form. Boulanger et al. (1981)
have shown that the positively charged tetracaine at low pH
mostly locates at the PC headgroup level, whereas the
uncharged form at high pH is intercalated partly in the
1 202 Biophysical Journal
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FIGURE 15 (a) 'H-NMR spectrum of dibucaine (3 mM) in sonicated PS liposomes prepared in deuterated phosphate buffer at pH 7.4. (b) 'H-NMR
spectrum of dibucaine (3 mM)-MP-2 (3 mM) in the sonicated PS liposomes. (c) 'H-NMR spectrum of dibucaine (3 mM)-MP-1 (3 mM) in the PS liposomes.
Assignments for the quinoline proton resonances are given on top of the spectrum (c).
headgroup region and partly in the fatty acyl chains of the
PC bilayers. The somewhat deeper binding of the neutral
tetracaine is also pointed out by the fluorescence quenching
experiment (Sikaris and Sawyer, 1982); the drug is oriented
in the bilayer so that its aromatic amine is near carbon 9 of
the fatty acyl chain of PC bilayers. For the PS bilayers, it is
also concluded that the charged and uncharged tetracaine
occupy different sites in the PS bilayer (Kelusky et al.,
1986). In the present data, however, we find no definite
reason to assume that the molecular form of dibucaine and
its protonated form locate at different depths in the bilayer,
at least to the precision of setting the carbon atom at the 3
position, based on the reasoning above. The differences in
the ratio ASCD/SCD noted between pH 7.2 and pH 5.2 can be
explained by the electrostatic interaction between the
charged dibucaine and the polar headgroup; hence we need
not invoke the changes in location of dibucaine upon pro-
tonation. The quadrupole splittings of both dibucaine-dl and
dibucaine-4 are always smaller at the acidic condition than
at the neutral condition. This can be explained by the
increased freedom of movement of dibucaine at the polar
headgroup region caused by the electrostatic interaction,
which separates lipid molecules from each other and results
in loose packing.
From the conclusions drawn about the location of dibu-
caine in model membranes, we may be allowed to conclude
that all local anesthetic molecules reside at the polar head-
group region of the membranes, which is capable of inter-
acting simultaneously with the hydrophobic amino acid
7.5 7.4 7.3 7.2 (ppm)
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FIGURE 16 Changes in chemical shifts (in units of Hz at 600 MHz) of
the quinoline proton resonances of dibucaine as a result of the interaction
with MP-1 and MP-2 in the PS liposomes.
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FIGURE 17 (a) 'H-NMR spectrum of the phenyl group protons of MP-1
(3 mM) in a phosphate buffer at pH 7.4. (b) 'H-NMR spectrum of the
phenyl group protons of dibucaine (3 mM)-MP-1 (3 mM) solution in a
phosphate buffer at pH 7.4. (c) 'H-NMR spectrum of the phenyl group
protons of MP-1 in the PS liposomes at pH 7.4. (d) 'H-NMR spectrum of
the phenyl group protons of dibucaine (3 mM)-MP-1 (3 mM) solution in
the PS liposomes at pH 7.4.
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FIGURE 18 Computer graphics view of relative arrangements among local anesthetic dibucaine, cholesterol, and dipalmitoylphosphatidylserine. The
dibucaine is presented as a face-to-face -7rstacked dimer.
residues at the intracellular linker part (Fig. 2). Interestingly,
Wang et al. have shown that there is a large hydrophobic
region within the Na+ channel pore in its cytoplasmic side,
which accepts up to 18 methylene groups of the quaternary
ammonium compounds; the hydrophobic domain also inter-
acts with local anesthetics such as cocaine and mepivacaine
(Wang et al., 1991). It seems very reasonable to assume that
the hydrophobic domain is formed by the lipids surrounding
the channel protein. Moreover, the lipids are not always
required to be organized as a bilayer, but they can exist as
a hexagonal phase (Dibble and Feigenson, 1994; Toumois
et al., 1987), implying that the drug, especially its aromatic
ring, can assume any convenient orientation to accommo-
date the three hydrophobic amino acids of the intracellular
linker.
Molecular mechanisms of local anesthesia
Local anesthetics are chemicals that reversibly block action
potentials in excitable membranes (Strichartz and Ritchie,
1987). They are usually composed of an aromatic ring, an
intermediate chain including an amide or an ester linkage,
and a tertiary amine nitrogen. They are amphiphilic in
nature and can exist as either cationic or uncharged molec-
ular forms, depending on the pKa of the drugs and pH of the
medium. As for the molecular mechanisms of anesthesia, it
is generally established that tertiary amine-type local anes-
thetics penetrate into the nerve sheath and nerve membrane
with their uncharged forms and bind to the Na+ channel at
the axoplasmic side of nerve membranes with their cationic
forms (Narahashi et al., 1970). However, benzocaine, which
lacks the ionizable tertiary amine at physiological pH, is
also known to be a local anesthetic drug. Thus there still
remain many controversial questions about the molecuar
mechanisms of local anesthesia: What is the site of anes-
thetic action? Is the site within lipids or within the Na+
channel protein? How many sites are there? Do both cat-
ionic and molecular forms of the drug bind at the same site?
etc. In attempting to solve these problems, we noticed the
publications on Na+ channel inactivation gate (Patton et al.,
1992; West et al., 1992), because it has already been shown
that local anesthetics promote the channel to close its inac-
tivation gate, stabilizing the inactivated state (Hille, 1977;
Postma and Catterall, 1984). Accordingly, we supposed that
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local anesthetics directly interact with the inactivation gate,
especially with its phenylalanine residue in the three clus-
tered hydrophobic amino acids of Ile-Phe-Met (Fig. 2),
because the phenylalanine residue is playing an essential
role in Na+ channel inactivation (West et al., 1992). This
assumption was also suggested to us by the fact that all local
anesthetics essentially bear an aromatic ring in their struc-
tures. We believe that the aromatic ring might be a prereq-
uisite group, not only for conferring lipophilicity on a drug
that allows it to pass through membranes, but also for
ir-stacked binding with the phenyl group of the phenylala-
nine residue. Thus we studied the interaction of local anes-
thetic dibucaine and the Na+ channel inactivation gate
peptides MP-1 and MP-2. One of the most serious concerns,
however, was whether dibucaine in a solution and in a lipid
bilayer membrane really interacts with the peptide at its
hydrophobic moieties. The present data shown in Figs. 14
and 16 clearly removed this concern. In addition, it was
found that the presence of lipids enhances the interaction.
This finding suggests firm evidence regarding the molecular
mechanisms of local anesthesia that the drug residing at the
polar headgroup region of the so-called boundary lipids in
the vicinity of the Na+ channel pore binds with the clustered
hydrophobic amino acids, especially with the phenylalanine
residue and results in stabilization of the inactivated state.
The drug binding with the phenylalanine residue may also
be facilitated by electrostatic interactions of its protonated
nitrogen with the negatively charged amino acids on both
sides of the IFM domain. Interestingly, Sheldon et al. have
shown in their structure-activity relationship study on the
lidocaine derivatives that there is an optimal distance be-
tween the aromatic ring and the tertiary amine nitrogen for
binding with the Na+ channel (Sheldon et al., 1991). Now
we can assign the optimal length to a range of distances
between the phenyl group of the phenylalanine residue and
the negative charge on the carboxyl group of the aspartic
acid, or between two glutamic acid residues that are situated
in positions before and after the IFM domain, respectively
(Fig. 2). Postma and Catterall (1984) and Wang et al. (1994)
have shown from their Hill coefficient data that one local
anesthetic drug binds with one inactivated channel. This
finding lends further support to our view that a local anes-
thetic drug binds to the IFM domain in the manner de-
scribed above. In Fig. 19 we show schematically the inter-
FIGURE 19 Computer graphics view for showing schematically the interaction between dibucaine, which resides at the polar headgroup region of
phosphatidylserine, and the inactivation gate peptide. The dibucaine is shown as a face-to-face nf-stacked dimer.
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action between dibucaine and the inactivation gate peptide;
one dibucaine dimer located at the polar headgroup region
of phosphatidylserine, 7r-stacking face-to-face with the
other, also interacts with the phenyl group of Phe-1489 by
u-stacking interaction with a T-shaped geometry, allowing
its protonated quaternary nitrogen to interact electrostati-
cally with the negatively charged carboxyl groups of two
adjacent glutamic acid residues of Glu-1492 and Glu-1493.
Finally, it should be added that Ragsdale et al. (1994)
have recently assigned the Phe-1764 residue in the sixth
segment of domain IV (Fig. 1) of rat brain type IIA Na+
channel to a plausible site of action of the local anesthetic
etidocaine. The Phe-1764 locates in the intermediate region
of the transmembrane helix and plays an important role in
fast inactivation of the Na+ channel (McPhee et al., 1995).
Interestingly, such a binding situation is reminiscent of the
binding of local anesthetic agents acting as noncompetitive
channel blockers for the nicotinic acetylcholine receptor
(Giraudat et al., 1987; Charnet et al., 1990), in the sense that
local anesthetic molecules can interact directly with trans-
membrane helices that form the lumen of the channel pore.
More recently, on the other hand, Bennett et al. (1995) have
indicated the importance of the IFM domain in the III-IV
linker for the lidocaine block of the human cardiac Na+
channel. This result strongly supports our conclusion. Evi-
dently more work is required to enlighten us about the
molecular mechanisms of local anesthesia.
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